All sponsors

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING3
READOUTS ≤12 MONTHS0
Open Juno Therapeutics, Inc., a Bristol-Myers Squibb Company on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
QUINTESSENTIAL
NCT06297226
P2RecruitingMultiple Myeloma2302026-07-31 (-2 mo)
BMS-986393
NCT06615479
P3RecruitingRelapsed or Refractory Multiple Myeloma (RRMM)4402027-12-30
Rituximab
NCT07015242
P2RecruitingLymphoma652028-01-09
CC-97540
NCT07015983
P2Active, not recruitingLupus Erythematosus, Systemic; Lupus Nephritis892028-05-17
Breakfree-SSc
NCT07335562
P3Not yet recruitingSystemic Sclerosis922028-11-14
BMS-986353
NCT07603557
P2Not yet recruitingChronic Immune Thrombocytopenia; Autoimmune Hemolytic Anemia522030-05-06